Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04984421
Other study ID # 2020-01198
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date June 30, 2025

Study information

Verified date November 2023
Source Karolinska Institutet
Contact Kristi S Annerstedt, PhD
Phone (0)70-9202081
Email kristi.sidney@ki.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

IMPROVE is an implementation study aiming to explore the effects of two bundled implementation strategies on the intervention fidelity of the Healthy School Start program (primary outcome) while simultaneously monitoring effects on health outcomes of children and parents (secondary outcomes). Thirty schools in two municipalities will receive the HSS program reaching about 1400 families per school year, for two years.


Description:

IMPROVE aims to conduct a hybrid type 3 evaluation design to test the effects of bundled implementation strategies on the intervention fidelity (primary outcome) of the Healthy School Start (HSS) program while simultaneously monitoring effects on health outcomes of children and parents (secondary outcomes). The HSS is a 4-component family support program for children starting school (5-7 years of age) promoting healthy dietary habits and physical activity in the home environment to prevent childhood obesity and parent risk of developing type 2 diabetes. IMPROVE is a cluster-randomized controlled trial with two arms to evaluate and compare the effects of two different bundles of implementation strategies on intervention fidelity expressed as adherence and responsiveness at 12 and 24 months. Thirty schools in two municipalities will participate in the study reaching about 1400 families per school year. In stakeholder workshops, key implementation determinants were identified according to the domains of the Consolidated Framework for Implementation Research. Through a consensus process with stakeholders, two bundles of implementation strategies were tailored to address context-specific determinants. Schools randomly assigned to group 1 will receive bundle 1 (Basic) and group 2 will receive bundle 1+2 (Enhanced), consisting mainly of external facilitation, fidelity monitoring and feedback strategies. Secondary outcomes will include acceptability, appropriateness, feasibility, organisational readiness as perceived by school staff, child weight status and diet, and parents' risk of type 2 diabetes. Linear and ordinal regression analysis will be used to test the effect on the primary and secondary outcomes, taking clustering into consideration where needed. Process evaluation will be conducted through key stakeholder interviews to investigate experiences of the program and stakeholder perceptions on sustainability. This systematic approach to investigating the effects of two different bundles of implementation strategies tailored to context-specific determinants on the fidelity of the HSS intervention will provide new insight into feasible implementation strategies and the external supports needed for a school-based health program like the HSS to be effective and sustainable. Results will help inform how to bridge the gap between the research on school-based health programs and routine practice in schools.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date June 30, 2025
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Years to 70 Years
Eligibility Inclusion Criteria: - All children and their parents at the included schools. All involved personnel at the included schools Exclusion Criteria: - No

Study Design


Intervention

Behavioral:
Healthy School Start
The Healthy School Start program is a universal 4-component family support program for children starting school (5-7 years of age) promoting healthy dietary habits and physical activity in the home environment to prevent childhood obesity and parents' risk of developing type 2 diabetes. It is targeting both children and parents.

Locations

Country Name City State
Sweden Municipality Huddinge Stockholm Region
Sweden Municipality Sigtuna Stockholm Region
Sweden Municipality Södertälje Stockholm Region

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in fidelity (A) assessed by questionnaire to parents and school staff Adherence to the four HSS components by indicators developed for this study. Information will be gathered through attendance logs and questionnaires to school staff and parents. Measured at 12 and 24 months
Primary Change in fidelity (R) assessed by questionnaire to parents Responsiveness to the four HSS components by indicators developed for this study. Information will be gathered through questionnaires to parents. Measured at 12 and 24 months
Secondary Change in acceptability of the HSS program assessed by questionnaire Feasibility of implementing the intervention as perceived by school staff, measured with the questionnaire developed by Weiner et al. Measured at baseline, 12, 24, and 36 months
Secondary Change in appropriateness of the HSS program measured by questionnaire Appropriateness of implementing the intervention as perceived by school staff, measured with the questionnaire developed by Weiner et al. Measured at baseline, 12, 24, and 36 months
Secondary Change in feasibility of the HSS program measured by questionnaire Feasibility of implementing the intervention as perceived by school staff, measured with the questionnaire developed by Weiner et al. Measured at baseline, 12, 24, and 36 months
Secondary Change in Organisational readiness of school principals assessed by questionnaire Organisational readiness to change as perceived by school principals with the Leader Readiness to Implement Tool (LRIT) Measured at baseline, 12, 24, and 36 months
Secondary Change in Organisational readiness by school staff assessed by questionnaire Organisational readiness to change as perceived by school nurses and teachers with the Staff Readiness to Implement Tool (SRIT) Measured at baseline, 12, 24, and 36 months
Secondary Fidelity to implementation strategies assessed by checklist Assessment based on checklist developed for this study. Each strategy will be graded as 0=not implemented, 1=partially implemented, 2=fully implemented. May each year
Secondary Change in child weight status assessed through measurement of height (m) and weight (kg) Child BMI will be calculated as in kg/m^2. Weight status will be assessed using age-appropriate BMI cut-off values for thinness, overweight and obesity according to the International Obesity Task Force. Measured at baseline and after 24 months
Secondary Change in child BMI z-score assessed through measurement of height (m) and weight (kg) Child BMI will be calculated as in kg/m^2. The BMI z-score will be calculated according to a Swedish reference standard (Karlberg). Measured at baseline and after 24 months
Secondary Change in child diet assessed by parent questionnaire Dietary indicator foods (fruit, vegetables and energy-dense products) assessed by the diet portion of the Eating and Physical Activity Questionnaire (EPAQ) Baseline, 12 months, and 24 months
Secondary Change in parental feeding practices assessed by parent questionnaire Assessed with the Swedish short version of the Comprehensive Feeding Practices Questionnire (CFPQ) Baseline, 12 months, and 24 months
Secondary Change in parents' risk of type 2 diabetes assessed by FINDRISC questionnaire The FINDRISC self-evaluation test to calculate risk of developing type 2 diabetes on a scale from 0-26 points Measured at Baseline, 12 months, and 24 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2

External Links